Johnson & Johnson's Drug to be Recommended for Rheumatoid Arthritis as Well

by Kathy Jones on  May 14, 2011 at 7:31 PM Drug News
RSS Email Print This Page Comment
After recommending Johnson & Johnson's drug Simponi as a treatment for psoriatic arthritis, Britain�s premier health agency, National Institute for Health and Clinical Excellence (NICE) on Friday said that the drug can also be used to treat rheumatoid arthritis.
 Johnson & Johnson's Drug to be Recommended for Rheumatoid Arthritis as Well
Johnson & Johnson's Drug to be Recommended for Rheumatoid Arthritis as Well

NICE had rejected the use of Simponi in treating psoriatic arthritis back in October but reversed its decision back in March after J&J said that they will be offering the drug in 100mg dose as well.

NICE has said that the drug can now be used in combination with methotrexate to treat rheumatoid arthritis in adults but only when the patient does not respond to the conventional anti-rheumatic drugs.

However the health agency added that J&J should offer 100mg doses of the drug for the same price of 50mg if it wants the drug to be paid for by Britain's state health service.




Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Drug Toxicity Osteoarthritis Rheumatoid Arthritis Oligoarthritis Spondylolisthesis Chemotherapy Chemotherapy Drugs Signature Drug Toxicity Knee Replacement Reiter’s syndrome 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive